Image via WikipediaMichigan Pharmaceutical Supplier’s DEA License Suspended - Harvard Drug Group, LLC distributed 13 million doses of Oxy from 2008-2010 is yet another warning shot to pharmaceutical distributors.
Adam Fein says "the DEA seems intent on holding drug wholesalers accountable for diversion of controlled substances by the wholesaler’s pharmacy customers." (The DEA Nabs Another Wholesaler)
Robert L. Corso, Special Agent in Charge of the Detroit Field Division, Drug Enforcement Administration (DEA), states in the DEA news release:
"Pharmaceutical companies have a responsibility to ensure that the drugs they sell don’t end up in the hands of drug traffickers or businesses that are conducting their business illegally. Harvard Drug Group, LLC, should have known, based on the large, frequent quantities, that their customers were diverting oxycodone into arenas that were not legitimate. Today’s action sends the message that the DEA is working hard to hold accountable those companies that are operating in a manner outside of federal law."Be forewarned.
Return Home: The Designated Representative and Exemptee Blog
Return Home (mobile): http://exemptee.mofuse.mobi/